Back to Search
RICHARD SCHILSKY, MD
MD
Hematology & Oncology Physician
NPI: 1235292749Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
Research & Publications (20)
Personalizing cancer care: American Society of Clinical Oncology presidential address 2009.
PMID 19581526·J Clin Oncol·2009
8-other
The Translational Research Working Group developmental pathway for anticancer agents (drugs or biologics).
PMID 18794076·Clin Cancer Res·2008
8-other
Target practice: oncology drug development in the era of genomic medicine.
PMID 17456516·Clin Trials·2007
8-other
First-line treatment options for patients with metastatic colorectal cancer.
PMID 16264820·Nat Clin Pract Oncol·2004
8-other
Inhibiting 5-fluorouracil breakdown: a broken down approach to 5-fluorouracil modulation.
PMID 12453336·Clin Colorectal Cancer·2002
8-other
Dose-escalating study of capecitabine plus gemcitabine combination therapy in patients with advanced cancer.
PMID 11786589·J Clin Oncol·2002
3-trial
Randomized, open-label, phase III study of a 28-day oral regimen of eniluracil plus fluorouracil versus intravenous fluorouracil plus leucovorin as first-line therapy in patients with metastatic/advanced colorectal cancer.
PMID 11896100·J Clin Oncol·2002
3-trial
Cooperative group tissue banks as research resources: the cancer and leukemia group B tissue repositories.
PMID 12006505·Clin Cancer Res·2002
8-other
Phase I clinical and pharmacological study of O6-benzylguanine followed by carmustine in patients with advanced cancer.
PMID 10955780·Clin Cancer Res·2000
3-trial
Pharmacology and clinical status of capecitabine.
PMID 11033828·Oncology (Williston Park)·2000
6-review
A multicenter phase II study of a five-day regimen of oral 5-fluorouracil plus eniluracil with or without leucovorin in patients with metastatic colorectal cancer.
PMID 10847459·Ann Oncol·2000
3-trial
Eniluracil: an irreversible inhibitor of dihydropyrimidine dehydrogenase.
PMID 11060767·Expert Opin Investig Drugs·2000
6-review
The impact of the privacy rule on cancer research: variations in attitudes and application of regulatory standards.
PMID 19620480·J Clin Oncol·2009
8-other
American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy.
PMID 19188670·J Clin Oncol·2009
6-review
Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
PMID 19103723·J Clin Oncol·2009
8-other
Tomorrow's cancer treatments today: the first 50 years of the Cancer and Leukemia Group B.
PMID 18929146·Semin Oncol·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 180 HARVESTER DR STE 110
BURR RIDGE, IL 60527 - Phone
- (773) 834-4064
Quick Facts
- NPI
- 1235292749
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile